165 related articles for article (PubMed ID: 25196202)
1. Outcomes of off-label drug uses in hospitals: a multicentric prospective study.
Danés I; Agustí A; Vallano A; Alerany C; Martínez J; Bosch JA; Ferrer A; Gratacós L; Pérez A; Olmo M; Marron SM; Valderrama A; Bonafont X
Eur J Clin Pharmacol; 2014 Nov; 70(11):1385-93. PubMed ID: 25196202
[TBL] [Abstract][Full Text] [Related]
2. Available evidence and outcome of off-label use of rituximab in clinical practice.
Danés I; Agustí A; Vallano A; Martínez J; Alerany C; Ferrer A; López A; Cortés-Hernández J; Bosch JA
Eur J Clin Pharmacol; 2013 Sep; 69(9):1689-99. PubMed ID: 23700188
[TBL] [Abstract][Full Text] [Related]
3. Is off-label use a risk factor for adverse drug reactions in pediatric patients? A prospective study in an Indian tertiary care hospital.
Saiyed MM; Lalwani T; Rana D
Int J Risk Saf Med; 2015; 27(1):45-53. PubMed ID: 25766066
[TBL] [Abstract][Full Text] [Related]
4. Association of Off-label Drug Use and Adverse Drug Events in an Adult Population.
Eguale T; Buckeridge DL; Verma A; Winslade NE; Benedetti A; Hanley JA; Tamblyn R
JAMA Intern Med; 2016 Jan; 176(1):55-63. PubMed ID: 26523731
[TBL] [Abstract][Full Text] [Related]
5. Adverse drug reactions and off-label and unlicensed medicines in children: a prospective cohort study of unplanned admissions to a paediatric hospital.
Bellis JR; Kirkham JJ; Nunn AJ; Pirmohamed M
Br J Clin Pharmacol; 2014 Mar; 77(3):545-53. PubMed ID: 23919928
[TBL] [Abstract][Full Text] [Related]
6. Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study.
Pratico AD; Longo L; Mansueto S; Gozzo L; Barberi I; Tiralongo V; Salvo V; Falsaperla R; Vitaliti G; La Rosa M; Leonardi S; Rotondo A; Avola N; Sgarlata D; Damiano A; Tirantello M; Anzelmo G; Cipolla D; Rizzo A; Russo A; Ruggieri M; Salomone S; Drago F
Curr Drug Saf; 2018; 13(3):200-207. PubMed ID: 29921210
[TBL] [Abstract][Full Text] [Related]
7. Experience with low-dose rituximab in off-label indications at two tertiary hospitals.
Chay J; Donovan P; Cummins L; Kubler P; Pillans P
Intern Med J; 2013 Aug; 43(8):871-82. PubMed ID: 23919335
[TBL] [Abstract][Full Text] [Related]
8. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
[TBL] [Abstract][Full Text] [Related]
9. Off-label use of tamoxifen in a Chinese tertiary care hospital.
Yang J; Lin W; Chen Y
Int J Clin Pharm; 2019 Apr; 41(2):555-562. PubMed ID: 30680514
[TBL] [Abstract][Full Text] [Related]
10. Perceptions and attitudes of Jordanian paediatricians towards off-label paediatric prescribing.
Mukattash TL; Wazaify M; Khuri-Boulos N; Jarab A; Hawwa AF; McElnay JC
Int J Clin Pharm; 2011 Dec; 33(6):964-73. PubMed ID: 21952953
[TBL] [Abstract][Full Text] [Related]
11. Adverse drug reactions and off-label and unlicensed medicines in children: a nested case-control study of inpatients in a pediatric hospital.
Bellis JR; Kirkham JJ; Thiesen S; Conroy EJ; Bracken LE; Mannix HL; Bird KA; Duncan JC; Peak M; Turner MA; Smyth RL; Nunn AJ; Pirmohamed M
BMC Med; 2013 Nov; 11():238. PubMed ID: 24229060
[TBL] [Abstract][Full Text] [Related]
12. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
Portolés J; López-Gómez JM; Aljama P
Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
[TBL] [Abstract][Full Text] [Related]
13. Off-label and unlicensed utilisation of medicines in a French paediatric hospital.
Joret-Descout P; Prot-Labarthe S; Brion F; Bataille J; Hartmann JF; Bourdon O
Int J Clin Pharm; 2015 Dec; 37(6):1222-7. PubMed ID: 26394784
[TBL] [Abstract][Full Text] [Related]
14. Prescribing of medicines in the Danish paediatric population outwith the licensed age group: characteristics of adverse drug reactions.
Aagaard L; Hansen EH
Br J Clin Pharmacol; 2011 May; 71(5):751-7. PubMed ID: 21241353
[TBL] [Abstract][Full Text] [Related]
15. A Multicenter Evaluation of Off-Label Medication Use and Associated Adverse Drug Reactions in Adult Medical ICUs.
Smithburger PL; Buckley MS; Culver MA; Sokol S; Lat I; Handler SM; Kirisci L; Kane-Gill SL
Crit Care Med; 2015 Aug; 43(8):1612-21. PubMed ID: 25855897
[TBL] [Abstract][Full Text] [Related]
16. Drug utilization and off-label drug use among Spanish emergency room paediatric patients.
Morales-Carpi C; Estañ L; Rubio E; Lurbe E; Morales-Olivas FJ
Eur J Clin Pharmacol; 2010 Mar; 66(3):315-20. PubMed ID: 19936729
[TBL] [Abstract][Full Text] [Related]
17. Unlicensed and off-label use of medicines in children admitted to the intensive care units of a hospital in Malaysia.
Lee JL; Redzuan AM; Shah NM
Int J Clin Pharm; 2013 Dec; 35(6):1025-9. PubMed ID: 24022725
[TBL] [Abstract][Full Text] [Related]
18. Measuring Safety and Outcomes for the Use of Compassionate and Off-Label Therapies for Children, Adolescents, and Young Adults With Cancer in the SACHA-France Study.
Berlanga P; Ndounga-Diakou LA; Aerts I; Corradini N; Ducassou S; Strullu M; de Carli E; André N; Entz-Werle N; Raimbault S; Roumy M; Renouard M; Gueguen G; Plantaz D; Reguerre Y; Cleirec M; Petit A; Puiseux C; Andry L; Klein S; Bodet D; Kanold J; Briandet C; Halfon-Domenech C; Nelken B; Piguet C; Saumet L; Chastagner P; Benadiba J; Millot F; Pluchart C; Schneider P; Thouvenin S; Gambart M; Serre J; Abbou S; Leruste A; Cayzac H; Gandemer V; Laghouati S; Vassal G
JAMA Netw Open; 2023 Jul; 6(7):e2321568. PubMed ID: 37399010
[TBL] [Abstract][Full Text] [Related]
19. Off-label use of rituximab in autoimmune disease in the Top End of the Northern Territory, 2008-2016.
Wongseelashote S; Tayal V; Bourke PF
Intern Med J; 2018 Feb; 48(2):165-172. PubMed ID: 28742259
[TBL] [Abstract][Full Text] [Related]
20. Off-label prescribing in pediatric outpatients.
Palmaro A; Bissuel R; Renaud N; Durrieu G; Escourrou B; Oustric S; Montastruc JL; Lapeyre-Mestre M
Pediatrics; 2015 Jan; 135(1):49-58. PubMed ID: 25511119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]